Access evidence-based clinical guidelines and technical standards to ensure your screening programme meets the highest standards.
Guidelines at a glance:
Discover the latest guidelines relating to lung cancer screening programmes.
- European Respiratory Society (ERS)/European Society of Radiology (ESR)
A narrative review of the evidence from LCS trials and a description of the current practices of LCS.
View the ERS/ESR Statement
- The European Society of Thoracic Imaging (ESTI)
A nodule management recommendation from ESTI to improve the handling of pulmonary nodules detected during screening.
View the ESTI recommendation
- International Early Lung Cancer Action Programme (I-ELCAP) Protocol
Standardised LDCT acquisition and quality assurance and information on detailed follow-up pathways and data registry.
View I-ELCAP
- American College of Radiology (ACR) Lung Reporting and Data System (RADS)
Structured CT reporting and management system with focus on standardising lesion categories and follow-up recommendations.
View Lung-RADS
- US Preventative Services Task Force (USPSTF) Screening Recommendations
Evidence-based guidelines for who should be screened (age, smoking history) including benefits and risks of screening.
View USPSTF Recommendations
- Brock Model (nodule malignancy risk calculator)
Calculates probability of malignancy for pulmonary nodules factoring in nodule size, morphology, patient risk factors.
View Brock Model
- American Cancer Society (ACS) Lung Cancer Screening Guidelines
Guidance on screening eligibility and patient communication along with resources for clinicians and programme planning.
View ACS Guidelines
- 4-IN-THE-LUNG-RUN Trial
European trial exploring population screening implementation and outcomes including insights on recruitment and delivery in European settings.
View 4-IN-THE-LUNG-RUN Trial